Diabetes Management Program for Hispanic/Latino
Type 2 Diabetes Mellitus, Type 2 Diabetes
About this trial
This is an interventional treatment trial for Type 2 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria:
- Hispanic patients with a diagnosis of diabetes
- Speaks English or Spanish
Exclusion Criteria:
- Patient is not Hispanic
- Patient does not have a diagnosis of diabetes
Sites / Locations
- Feinstein Institute of Medical Research
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Diabetes Telemonitoring (DTM)
Comprehensive Outpatient Management (COM)
Diabetes Telehealth Management (DTM), based on the 2018 ADA Standards for Type 2 Diabetes (T2D), uses smart devices to share information between patients, caregivers, and clinicians. DTM includes:1) weekly real time "virtual" visit between patient and clinician 2) vital signs monitoring/interpretation 3) diabetes management 4) patient interactive educational videos and "teach back" quizzes, reinforcing self-management strategies 5) a caregiver app with supportive capability.
Comprehensive Outpatient Management (COM) is the most realistic evidence-based comparator, in that it is the most frequently recommended and used option for US T2D patients. COM, like DTM, is consistent with the 2018 American Diabetes Association (ADA) Standards which include, but are not limited to, past medical and family history, social history, medications, screening, physical examination, laboratory evaluation, etc.Patients are instructed to monitor blood glucose (within physician recommendations), and have routine or "well" visits every 3 months. Patients can set appointments with a T2D educator. COM patients will receive monthly calls from the study Registered Nurse (RN) to collect data.